Bonito Biosciences and DaltonTx Announce AI-Driven Collaboration to Advance Precision Delivery for Oligotherapeutics
Collaboration combines Bonito’s proprietary functional delivery data engine and ligand discovery platform…
Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer
Study now open for enrollment at leading academic medical centersCARY, N.C. and…
Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026
April 13, 2026 09:00 ET | Source: Senti Biosciences, Inc. SOUTH SAN…
Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
March 27, 2026 10:40 ET | Source: Artelo Biosciences SOLANA BEACH, Calif.,…
Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE Cell-Therapy Platform Toward First-in-Human Study
Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study…
Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation
-- Issues Statement in Response to DOMA’s Nomination of Director Candidates --…
CORRECTING & REPLACING — MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
Following End-of-Phase 2 meeting, MBX remains on track to initiate Phase 3…
Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting
February 28, 2026 09:45 ET | Source: Cogent Biosciences, Inc. Bezuclastinib mean…
Lifespan Vision Ventures Co-Leads Sift Biosciences’ $3.7M Pre-Seed Financing
NORWALK, Conn., Feb. 18, 2026 /PRNewswire/ -- Lifespan Vision Ventures, an investment…
Waters Completes Combination with BD’s Biosciences & Diagnostic Solutions Businesses
Announces appointment of Claire M. Fraser, Ph.D., to its Board of DirectorsForms…
